Bausch Health Companies Inc. BHC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.91B | 2.83B | 2.50B | 2.77B | 2.66B |
| Total Other Revenue | 29.00M | 27.00M | 24.00M | 28.00M | 24.00M |
| Total Revenue | 2.94B | 2.85B | 2.52B | 2.80B | 2.68B |
| Cost of Revenue | 735.00M | 772.00M | 738.00M | 798.00M | 750.00M |
| Gross Profit | 2.21B | 2.08B | 1.79B | 2.00B | 1.93B |
| SG&A Expenses | 834.00M | 907.00M | 860.00M | 880.00M | 795.00M |
| Depreciation & Amortization | 227.00M | 225.00M | 241.00M | 236.00M | 253.00M |
| Other Operating Expenses | -2.00M | -- | 1.00M | -- | -6.00M |
| Total Operating Expenses | 1.94B | 2.08B | 2.00B | 2.08B | 1.96B |
| Operating Income | 1.01B | 775.00M | 521.00M | 721.00M | 723.00M |
| Income Before Tax | 597.00M | 348.00M | -1.35B | 56.00M | 218.00M |
| Income Tax Expenses | 151.00M | 88.00M | 77.00M | 159.00M | 37.00M |
| Earnings from Continuing Operations | 446.00M | 260.00M | -1.43B | -103.00M | 181.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -10.00M | -2.00M | 8.00M | -9.00M | -2.00M |
| Net Income | 436.00M | 258.00M | -1.42B | -112.00M | 179.00M |
| EBIT | 1.01B | 775.00M | 521.00M | 721.00M | 723.00M |
| EBITDA | 1.29B | 1.06B | 816.00M | 1.01B | 1.03B |
| EPS Basic | 1.16 | 0.69 | -3.82 | -0.30 | 0.48 |
| Normalized Basic EPS | 1.01 | 0.63 | 0.22 | 0.52 | 0.53 |
| EPS Diluted | 1.15 | 0.68 | -3.82 | -0.30 | 0.48 |
| Normalized Diluted EPS | 0.99 | 0.63 | 0.22 | 0.52 | 0.53 |
| Average Basic Shares Outstanding | 375.50M | 375.00M | 372.80M | 373.33M | 371.30M |
| Average Diluted Shares Outstanding | 380.70M | 378.10M | 372.80M | 373.33M | 375.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |